Read + Share
Bril V, Druzdz A, Grosskreutz J, Habib AA, et al. Safety and efficacy of chronic weekly rozanolixizumab in generalized myasthenia
gravis: the randomized open-label extension MG0004 study. J Neurol 2025;272:275.
PMID: 40105996
|
 |
|
Bril V, Druzdz A, Grosskreutz J, Habib AA, et al. Safety and efficacy of chronic weekly rozanolixizumab in generalized myasthenia
gravis: the randomized open-label extension MG0004 study. J Neurol 2025;272:275.
PMID: 40105996
|
|
|
|